We are live on ! Find out more
CLSD

Clearside Biomedical
CLSD

Delisted

CLSD was delisted on the 28th of November, 2025.

Back to rankings

47 hedge funds and large institutions have $23M invested in Clearside Biomedical in 2019 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

423% more capital invested

Capital invested by funds: $4.41M → $23M (+$18.6M)

217% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 6

38% more funds holding

Funds holding: 34 → 47 (+13)

0.05% more ownership

Funds ownership: 1.23% → 1.29% (+0.05%)

20% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 10

86% less call options, than puts

Call options by funds: $254K | Put options by funds: $1.83M

Holders
47
Holders Change
+13
Holders Change %
+38.24%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
8
Reduced
10
Closed
6
Calls
$254K
Puts
$1.83M
Net Calls
-$1.58M
Net Calls Change
-$1.58M

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$434K
2
BlackRock
BlackRock
New York
+$251K
3
Group One Trading
Group One Trading
Illinois
+$213K
4
OAM
Oxford Asset Management
United Kingdom
+$185K
5
Renaissance Technologies
Renaissance Technologies
New York
+$124K

Top Sellers

Rank Fund Capital Flow
1
S
SignatureFD
Georgia
-$176K
2
PA
Parallel Advisors
California
-$85.6K
3
Millennium Management
Millennium Management
New York
-$41.3K
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$34.3K
5
WS
Wedbush Securities
California
-$29K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$61K – – –
JIC
27
Johnson Investment Counsel
Ohio
$58K – – –
IAN
28
Integrated Advisors Network
Texas
$46K +$22K +1,047 New
AG
29
Aperio Group
California
$45K -$7.12K -339 -25%
DLHL
30
Donald L. Hagan LLC
Florida
$40K +$19.6K +933 New
Stifel Financial
31
Stifel Financial
Missouri
$39K -$4.2K -200 -19%
GPFA
32
Game Plan Financial Advisors
Ohio
$32K +$15.4K +733 New
LC
33
Lindbrook Capital
California
$29K +$14K +667 New
BC
34
Barnett & Company
Tennessee
$15K +$7K +333 New
VCP
35
Verus Capital Partners
Arizona
$15K +$7K +333 New
Citigroup
36
Citigroup
New York
$9K – – –
LTFS
37
Ladenburg Thalmann Financial Services
Florida
$7K – – –
PA
38
Parallel Advisors
California
$6K -$85.6K -4,073 -97%
TFS
39
TrustCore Financial Services
Tennessee
$6K – – –
NFG
40
Next Financial Group
Texas
$6K +$2.79K +133 New
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
$3K -$210 -10 -13%
CG
42
Cutler Group
California
$3K – – –
TCWM
43
Total Clarity Wealth Management
Illinois
$2K +$1.11K +53 New
AG
44
Advisor Group
Arizona
$1K +$357 +17 New
CP
45
Corbenic Partners
Pennsylvania
$1K +$504 +24 New
BNP Paribas Financial Markets
46
BNP Paribas Financial Markets
France
$168 -$4.33K -206 -98%
LP
47
LMR Partners
United Kingdom
– -$15K -1,536 Closed
Bank of America
48
Bank of America
North Carolina
– -$4K -400 Closed
Victory Capital Management
49
Victory Capital Management
Texas
– -$4K -379 Closed
SF
50
Synovus Financial
Georgia
– -$3K -333 Closed
1
2
3

CLSD Hedge Fund Activity: Q4 2019 in Review

47 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Clearside Biomedical (CLSD) for Q4 2019, worth a combined $23M — up 423% from $4.41M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new CLSD positions and 6 closed out — a net gain of 13 holders — while 8 added to existing stakes and 10 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $434K. The largest seller was SignatureFD, cutting an estimated $176K.

  • 47 institutional investors held Clearside Biomedical (CLSD) as of Q4 2019, up from 34 in Q3 2019.
  • Funds reported $23M of Clearside Biomedical stock for Q4 2019, up 423% quarter-over-quarter.
  • 19 funds opened new Clearside Biomedical positions in Q4 2019 and 6 closed out, a net change of +13 holders.
  • The largest Clearside Biomedical buyer in Q4 2019 was Susquehanna International Group, an estimated $434K added.
  • The largest Clearside Biomedical seller in Q4 2019 was SignatureFD, an estimated $176K sold.

Based on aggregated 13F filings for Q4 2019.